Kimia Farma Tbk.

KAEF · Kesehatan · Farmasi & Riset Kesehatan

348

-36.73% 1-year change

Last completed session, Oct 16, 2026

Daily closes over the past year, to Oct 16, 2026

What makes up the 25

  • Value

    29Against 788 other IDX companies

    Expensive against comparable stocks.

    P/E
    Loss
    10%Cheaper than 10% of other IDX companies
    P/B
    0.67×
    72%Cheaper than 72% of other IDX companies
    Dividend yield
    0%
    4%Higher than 4% of other IDX companies
  • Quality

    19Against 788 other IDX companies

    Less profitable than most comparable stocks.

    Return on equity
    -7.9%
    14%Higher than 14% of other IDX companies
    Return on assets
    -1.7%
    21%Higher than 21% of other IDX companies
    Net margin
    -2.7%
    22%Higher than 22% of other IDX companies
  • Growth

    33Against 788 other IDX companies

    Growing slower than most comparable stocks.

    Profit, last 4 quarters
    —
    —Not ranked
    Profit, 3-year yearly
    —
    —Not ranked
    Profit, latest quarter vs a year ago
    -995.3%
    3%Higher than 3% of other IDX companies
    Revenue, latest quarter vs a year ago
    +21.3%
    63%Higher than 63% of other IDX companies
  • Momentum

    22Against 836 traded stocks

    Has lagged most stocks over the past year.

    1-year price change
    -42.5%
    22%Better than 22% of traded stocks
  • Liquidity

    36Against 836 traded stocks

    Thinly traded compared with most IDX stocks.

    Value traded per day, 30 days
    IDR 439M
    36%Higher than 36% of traded stocks
  • Retail penalty

    −3Retail brokers XL, XC, RO, YP, past 20 sessions

    Retail is underwater here, deeper than 56% of the other stocks where it is, so 3 points come off the rating.

    Retail average buy
    421
    Close vs that average
    -17.4%
    Retail net bought
    -11K lots

Similar stocks

Rated most like KAEF across the five pillars. Change is over the past year.